
Prolactin
Prolactin
What it is
Prolactin is a peptide hormone produced and secreted by lactotroph cells of the anterior pituitary gland. It is best known for its role in initiating and sustaining lactation after childbirth — but prolactin receptors are expressed in immune cells, adipose tissue, liver, kidney, adrenal cortex, and the central nervous system, reflecting a broader physiological role that extends beyond reproduction. Unlike most pituitary hormones, prolactin secretion is under tonic inhibitory control by dopamine from the hypothalamus — dopamine continuously suppresses prolactin release, and anything that reduces dopaminergic tone will raise prolactin levels. Prolactin is also secreted in response to physical stress, exercise, sleep, nipple stimulation, sexual orgasm, and hypoglycaemia — making the timing and conditions of the blood draw critical for accurate interpretation. Elevated prolactin outside the context of pregnancy and breastfeeding is called hyperprolactinaemia.
Why we measure it
Pathological hyperprolactinaemia disrupts the hypothalamic-pituitary-gonadal axis by suppressing GnRH pulsatility. The mechanism is direct: elevated prolactin reduces the frequency and amplitude of GnRH pulses from the hypothalamus, which in turn reduces FSH and LH secretion, which reduces gonadal sex hormone production. In males, this manifests as low testosterone, reduced libido, erectile dysfunction, and infertility — a presentation virtually identical to primary hypogonadism, but arising from an entirely different cause requiring different management. In females, hyperprolactinaemia causes oligo- or amenorrhoea, anovulation, galactorrhoea (inappropriate milk production), and infertility. Because its symptoms overlap with many common conditions — depression, fatigue, low libido — hyperprolactinaemia is frequently missed for years. The most common causes are: prolactinoma (a benign anterior pituitary adenoma producing prolactin, by far the most common pituitary tumour); medications that block dopamine receptors or reduce dopaminergic tone (antipsychotics, metoclopramide, domperidone, some antidepressants, some antihypertensives); hypothyroidism (TRH stimulates prolactin secretion alongside TSH); and chronic renal disease (impaired prolactin clearance). Annual prolactin testing catches hyperprolactinaemia in its early phase, before it causes measurable hypogonadism, and directs clinical investigation toward the correct diagnosis.
Why every 6 months
Prolactin has a diurnal pattern — it is highest during sleep and in the early morning. Blood should be drawn fasting, in the morning, after at least 30 minutes of rest (stress, physical activity, and venepuncture anxiety can all transiently raise prolactin). Macroprolactin — a high-molecular-weight complex of prolactin with immunoglobulin G — can be present in some individuals and produce an elevated total prolactin with normal bioactive prolactin; laboratories can perform a polyethylene glycol (PEG) precipitation test to distinguish these. The six-month interval provides sufficient resolution to detect a rising trend or confirm persistent elevation.
What movement means
Standard laboratory reference ranges for serum prolactin in non-pregnant adults are approximately 4–23 ng/mL (86–496 mIU/L) for females and 3–15 ng/mL (65–324 mIU/L) for males, though ranges vary by assay. A single mildly elevated reading should be repeated under optimal conditions (fasting, rested, no recent exercise or sexual activity) before clinical action. Prolactinomas are classified by size: microadenomas (< 10 mm) and macroadenomas (≥ 10 mm); the latter are more likely to produce very high prolactin levels and can cause mass effects on adjacent pituitary structures.
Normal
3 – 15 ng/mL (male) · 4 – 23 ng/mL (female, non-pregnant)
Within the reference range. Confirm the draw was taken under standardised conditions (fasting, morning, ≥30 min rest). In females, normal ranges vary across the menstrual cycle and are substantially higher during pregnancy and lactation.
Standard laboratory reference ranges — vary by assay method
Mildly Elevated
25 – 100 ng/mL (530 – 2120 mIU/L)
Mild hyperprolactinaemia. Common causes include stress at the time of draw, medications (antipsychotics, antidepressants, metoclopramide), hypothyroidism, and macroprolactinaemia. Repeat measurement under standardised conditions is recommended before clinical investigation. Check TSH.
Melmed S et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2011 — doi:10.1210/jc.2010-1oso
Significantly Elevated
> 100 ng/mL (> 2120 mIU/L)
Strongly associated with prolactinoma, particularly values > 200 ng/mL. Pituitary MRI and specialist endocrinology assessment are recommended. Dopamine agonist therapy (cabergoline, bromocriptine) is highly effective for prolactinomas of all sizes.
Melmed S et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2011
In the protocol
References
- 1.
Melmed S, Casanueva FF, Hoffman AR, et al.. “Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism. 2011.
- 2.
Colao A, Lombardi G. “Growth-Hormone and Prolactin Excess.” The Lancet. 1998.
- 3.
Majumdar A, Mangal NS. “Hyperprolactinemia.” Journal of Human Reproductive Sciences. 2013.
- 4.
Touraine P, Martinie M, Coste J, et al.. “Sleeping Difficulties and Their Hormonal Correlates in Women on Hormone Replacement Therapy.” Fertility and Sterility. 2000.